MIDI (MR Imaging Abnormality Deep Learning Identification) — MIDI  

Neurological Disorder Clinical Trial

Official title: Deep Learning for Identification of Abnormalities on Head MRI

Status Recruiting

Clinical Trial Summary

The study involves the development and testing of an artificial intelligence (AI) tool that can identify abnormalities using patient head scans conducted for routine clinical care and research volunteer scans. A deep learning algorithm will be developed using a dataset of retrospective and prospective MRI head scans to train, validate, and test convolutional networks using software developed at the Department of Biomedical Engineering, King's College London. The reference standard will be consultant radiologist reports of the MRI head scans.

Clinical Trial Description

An automated strategy for identifying abnormalities in head scans could address the unmet clinical need for faster abnormality identification times, potentially allowing for early intervention to improve short- and long-term clinical outcomes. Radiologist shortages and increased demand for MRI scans lead to delays in reporting, particularly in the outpatient setting.

Furthermore, there is a wide variation in the management of incidental findings (IFs) discovered in 'healthy volunteers.' The routine reporting of 'healthy volunteer' scans by a radiologist poses logistical and financial challenges. It would be valuable to devise automated strategies to reliably and accurately identify IFs, potentially reducing the number of scans requiring routine radiological review by up to 90%, thus increasing the feasibility of implementing a routine reporting strategy.

Deep learning is a novel technique in computer science that automatically learns hierarchies of relevant features directly from the raw inputs (such as MRI or CT) using multi-layered neural networks. A deep learning algorithm will be trained on a large database of head MRI scans to recognize scans with abnormalities. This algorithm will be trained to classify a subset of these scans as normal or abnormal and then tested on an independent subset to determine its validity.

If the tested neural network demonstrates high diagnostic accuracy, future research participants and patients may benefit, as not all institutions currently review their research scans for incidental findings and clinical scans may not be reported for weeks in some cases. In both research and clinical scenarios, an algorithm could rapidly identify abnormal pathology and prioritize scans for reporting.

In summary, the aim is to develop a deep learning abnormality detection algorithm for use in both research and clinical settings. ;

Related Conditions & MeSH terms

• Nervous System Diseases
• Neurological Disorder

• NCT number: NCT04368481
• Study type: Observational
• Source: King's College Hospital NHS Trust
• Contact: MIDI Central Team
• Phone: +44(0)20 7848 9670
• Email: kch-tr.midistudy@nhs.net
• Status: Recruiting
• Start date: April 1, 2019
• Completion date: March 31, 2025